Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

75,239 questions in 5,342 reviews

current versions
No studies 15,213 · 20.2%Ungraded 10,323 · 13.7%Very low 17,528 · 23.3%Low 17,951 · 23.9%Moderate 11,190 · 14.9%High 3,034 · 4%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Sublingual immunotherapy vs placebo
Total ocular symptom scores Symptom scores · patients with allergic conjunctivitis
Sublingual immunotherapy for treating allergic conjunctivitis (2011) · Cochrane
no estimate extracted36 studies · 3399 participantsModerate
Sublingual immunotherapy vs placebo
Itchy/Gritty eyes Symptom scores · patients with allergic conjunctivitis
Sublingual immunotherapy for treating allergic conjunctivitis (2011) · Cochrane
no estimate extracted28 studies · 3020 participantsModerate
Sublingual immunotherapy vs placebo
Watery eyes Symptom scores · patients with allergic conjunctivitis
Sublingual immunotherapy for treating allergic conjunctivitis (2011) · Cochrane
no estimate extracted21 studies · 2641 participantsModerate
Sublingual immunotherapy vs placebo
Red eyes Symptom scores · patients with allergic conjunctivitis
Sublingual immunotherapy for treating allergic conjunctivitis (2011) · Cochrane
no estimate extracted20 studies · 1211 participantsModerate
Sublingual immunotherapy vs placebo
Eye drops Symptom scores · patients with allergic conjunctivitis
Sublingual immunotherapy for treating allergic conjunctivitis (2011) · Cochrane
no estimate extracted13 studies · 1038 participantsModerate
Sublingual immunotherapy vs placebo
Combined symptom‐medication scores Symptom scores · patients with allergic conjunctivitis
Sublingual immunotherapy for treating allergic conjunctivitis (2011) · Cochrane
no estimate extracted3 studies · 351 participantsModerate
Sublingual immunotherapy vs placebo
Conjunctival immediate allergen sensitivity Symptom scores · patients with allergic conjunctivitis
Sublingual immunotherapy for treating allergic conjunctivitis (2011) · Cochrane
no estimate extracted4 studies · 250 participantsModerate
Vaccination vs placebo
Persistence of PHN among all subjects a numerical rating scale for pain1 · people at risk for postherpetic neuralgia
Vaccination for preventing postherpetic neuralgia (2011) · Cochrane
RR 0.31 [0.18, 0.54]1 study · 38501 participantsHigh
Vaccination vs placebo
Persistence of PHN among subjects developing herpes zoster a numerical rating scale for pain1 · people at risk for postherpetic neuralgia
Vaccination for preventing postherpetic neuralgia (2011) · Cochrane
RR 0.64 [0.38, 1.09]1 study · 957 participantsModerate
Vaccination vs placebo
Deaths among all subjects during the whole study clinical · people at risk for postherpetic neuralgia
Vaccination for preventing postherpetic neuralgia (2011) · Cochrane
RR 1 [0.91, 1.1]1 study · 38546 participantsHigh
Vaccination vs placebo
Serious adverse events among subjects in the adverse event substudy clinical manifestations · people at risk for postherpetic neuralgia
Vaccination for preventing postherpetic neuralgia (2011) · Cochrane
RR 1.53 [1.03, 2.25]1 study · 6616 participantsHigh
Intervention NR
Consistent condom use ‐ 3 months Self‐report · patients with women living with HIV
Behavioral interventions to promote condom use among women living with HIV (2011) · Cochrane
OR 0.72 [0.43, 1.2]3 studies · 272 participantsLow
Intervention NR
Consistent condom use ‐ 6 months Self‐report · patients with women living with HIV
Behavioral interventions to promote condom use among women living with HIV (2011) · Cochrane
OR 0.96 [0.66, 1.4]4 studies · 637 participantsLow
Intervention NR
Consistent condom use ‐ 12 months Self‐report · patients with women living with HIV
Behavioral interventions to promote condom use among women living with HIV (2011) · Cochrane
OR 0.75 [0.51, 1.11]2 studies · 487 participantsLow
Intervention NR
Incidence of STI3 ‐ not reported · patients with women living with HIV
Behavioral interventions to promote condom use among women living with HIV (2011) · Cochrane
no estimate extractedNRNo studies
Phototherapy with LED vs non‐LED light source
Duration of phototherapy hours · neonates with unconjugated hyperbilirubinaemia
Light‐emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates (2011) · Cochrane
no estimate extracted6 studies · 630 participantsHigh
Phototherapy with LED vs non‐LED light source
Rate of decline of serum total bilirubin mg/dL/hour · neonates with unconjugated hyperbilirubinaemia
Light‐emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates (2011) · Cochrane
no estimate extracted4 studies · 511 participantsHigh
Intervention NR
Peak exercise capacity: Power (W) · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted8 studies · 367 participantsModerate
Intervention NR
Peak exercise capacity: Peak oxygen consumption (VO2peak) (L/min) · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted5 studies · 188 participantsModerate
Intervention NR
Peak exercise test: Lactate threshold (L/min) · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted3 studies · 94 participantsModerate
Intervention NR
Peak exercise test: Isowork minute ventilation (VE) (L) · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted2 studies · 77 participantsLow
Intervention NR
Peak exercise test: Isowork dyspnoea score · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted1 study · 36 participantsLow
Intervention NR
Exercise tolerance: Endurance time (min) · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted1 study · 41 participantsLow
Intervention NR
Functional exercise capacity: Six‐minute walk distance (m) · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted6 studies · 287 participantsLow
Intervention NR
Health‐related Quality of Life: Dyspnoea domain of the CRQ · people with chronic obstructive pulmonary disease
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (2011) · Cochrane
no estimate extracted4 studies · 212 participantsModerate
Spinal manipulative therapy vs inert interventions
Pain VAS. Scale from 0‐100 (worse pain). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 72 participantsVery low
spinal manipulative therapy (SMT) vs sham SMT
Functional status Roland Morris Disability Questionnaire. Scale from: 0 to 24 (worse function). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 51 participantsVery low
Spinal manipulative therapy vs all other interventions
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted6 studies · 1405 participantsHigh
Spinal manipulative therapy vs all other interventions
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted5 studies · 1074 participantsModerate
Spinal manipulative therapy vs all other interventions
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted3 studies · 1285 participantsHigh
Spinal manipulative therapy vs all other interventions
Functional status Roland Morris Disability Questionnaire. Scale from: 0 to 24 (worse function). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted6 studies · 1402 participantsHigh
Spinal manipulative therapy vs all other interventions
Functional status Roland Morris Disability Questionnaire. Scale from: 0 to 24 (worse function). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted6 studies · 1323 participantsModerate
Spinal manipulative therapy vs all other interventions
Functional status Roland Morris Disability Questionnaire. Scale from 0 to 24 (worse function). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted4 studies · 1418 participantsHigh
Spinal manipulative therapy vs all other interventions
Recovery at 1 month · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
RR 1.2 [1.04, 1.37]3 studies · 370 participantsModerate
spinal manipulative therapy plus any intervention vs the intervention alone
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted3 studies · 228 participantsLow
spinal manipulative therapy plus any intervention vs the intervention alone
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted2 studies · 1016 participantsHigh
Spinal manipulative therapy vs inert interventions
Pain VAS. Scale from 0‐100 (worse pain). · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 70 participantsVery low
spinal manipulative therapy plus any intervention vs the intervention alone
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted2 studies · 1000 participantsHigh
spinal manipulative therapy plus any intervention vs the intervention alone
Functional status Roland Morris Disability Questionnaire. Scale from: 0 to 24 (worse function). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted2 studies · 156 participantsLow
spinal manipulative therapy plus any intervention vs the intervention alone
Functional status Roland Morris Disability Questionnaire. Scale from: 0 to 24 (worse function) . · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted2 studies · 1078 participantsHigh
spinal manipulative therapy plus any intervention vs the intervention alone
Functional status Roland Morris Disability Questionnaire. Scale from: 0 to 24 (worse function). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 994 participantsHigh
spinal manipulative therapy plus any intervention vs the intervention alone
Recovery at one month · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
RR 3.4 [1.12, 10.28]1 study · 32 participantsVery low
Spinal manipulative therapy vs inert interventions
Recovery at 1 month · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
RR 1.03 [0.49, 2.19]1 study · 72 participantsVery low
Spinal manipulative therapy vs inert interventions
Recovery at 3 months · patients with chronic low‐back pain
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
RR 0.96 [0.56, 1.65]1 study · 70 participantsVery low
spinal manipulative therapy (SMT) vs sham SMT
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted3 studies · 148 participantsVery low
spinal manipulative therapy (SMT) vs sham SMT
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 55 participantsVery low
spinal manipulative therapy (SMT) vs sham SMT
Pain VAS. Scale from: 0‐100 (worse pain). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 51 participantsVery low
spinal manipulative therapy (SMT) vs sham SMT
Functional status Roland Morris Disability Questionnaire. Scale from 0 to 24 (worse function). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 65 participantsVery low
spinal manipulative therapy (SMT) vs sham SMT
Functional status Roland Morris Disability Questionnaire. Scale from: 0 to 24 (worse function). · patients with chronic LBP
Spinal manipulative therapy for chronic low‐back pain (2011) · Cochrane
no estimate extracted1 study · 55 participantsVery low
Intervention NR
Primary outcomes and adverse effects · Preschool children from socially disadvantaged families
Home‐based child development interventions for preschool children from socially disadvantaged families (2011) · Cochrane
no estimate extractedNRNo studies